OTTMUSG00000007521 Inhibitors
Chemical Inhibitors of MSANTD5 can potentially exert their inhibitory effects through distinct mechanisms that target specific signaling pathways closely associated with the protein's function. Tofacitinib, a Janus kinase (JAK) inhibitor, can indirectly inhibit the putative uncharacterized protein MSANTD5 by disrupting the JAK-STAT signaling pathway. This pathway plays a pivotal role in cytokine-mediated cellular responses, and interference with JAK signaling can lead to a downstream impact on the protein's functional processes. Similarly, Rapamycin, an mTOR inhibitor, has the potential to influence MSANTD5 by modulating the mTOR signaling pathway, which governs various cellular functions. Alterations in mTOR activity could indirectly affect the protein's role within these cellular processes.
Wortmannin, a phosphatidylinositol 3-kinase (PI3K) inhibitor, may act as an indirect inhibitor by perturbing the PI3K-AKT signaling pathway. This pathway is intricately connected to cellular processes that intersect with the function of the protein MSANTD5. Furthermore, SB-203580, a p38 MAP kinase inhibitor, could potentially inhibit the protein through its impact on the p38 MAPK pathway, which plays a role in diverse cellular responses and signaling events that may relate to the protein's function. These inhibitors, along with the others mentioned in the table, offer distinct avenues for potential functional inhibition of MSANTD5 by targeting specific signaling pathways. It is important to note that these mechanisms are based on logical analysis of known pathways and cellular processes, and further experimental studies would be required to validate their precise impact on the protein's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. It may indirectly inhibit the function of MSANTD5 by affecting the mTOR signaling pathway, which plays a role in regulating various cellular processes, potentially including those related to the protein's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a phosphatidylinositol 3-kinase (PI3K) inhibitor. It could potentially inhibit putative uncharacterized protein MSANTD5 by influencing the PI3K-AKT signaling pathway, which is involved in many cellular processes and may intersect with the protein's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB-203580 is a p38 MAP kinase inhibitor. It might indirectly inhibit the function of the protein MSANTD5 by affecting the p38 MAPK pathway, which has connections to various cellular responses and signaling events that could be related to the protein's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY-294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. It may indirectly inhibit the function of putative uncharacterized protein MSANTD5 by affecting the PI3K-AKT signaling pathway, which is involved in diverse cellular processes that could be relevant to the protein. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 is a JAK2 inhibitor. It may indirectly inhibit the function of MSANTD5 by disrupting the JAK-STAT signaling pathway, which is implicated in various cellular functions and may have connections to the protein's role in specific contexts. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 is a TGF-β receptor inhibitor. It might indirectly inhibit the function of the protein MSANTD5 by interfering with the TGF-β signaling pathway, which plays roles in various cellular processes that could be related to the protein's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. It could potentially inhibit putative uncharacterized protein MSANTD5 by affecting the JNK signaling pathway, which is involved in cellular responses and signaling events that may intersect with the protein's function in specific contexts. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK1/2 inhibitor. It may indirectly inhibit the function of MSANTD5 by influencing the MAPK/ERK signaling pathway, which is vital for numerous cellular processes and may have relevance to the protein's function in specific scenarios. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
LY-411575 is a γ-secretase inhibitor. It might indirectly inhibit the function of the protein MSANTD5 by affecting the Notch signaling pathway, which has connections to various cellular responses and events that could be related to the protein's function. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
SP2509 is a Notch signaling inhibitor. It could potentially inhibit putative uncharacterized protein MSANTD5 by influencing the Notch signaling pathway, which is involved in diverse cellular processes that might intersect with the protein's function in specific contexts. | ||||||